Skip to main content
letter
. 2018 Nov;15(11):1359–1362. doi: 10.1513/AnnalsATS.201804-262RL

Table 1.

Relevant clinical and pathologic information

Patient Death Circumstance Age at Onset of Asthma Number of Prior Hospital Visits Medications Comorbid Conditions Right Ventricular Hypertophy Airways with Plug Inflamed Airways Loose Mucus in Airways Basement Membrane Thickening Open IBA PA Muscular Hypertrophy BA Remodeling
1 Morning wheezing treated with nebulizer, during last treatment developed cardiorespiratory arrest leading to severe anoxic brain injury on the first day, support withdrawn on the fourth day of hospitalization Unknown 2 Unknown None No 3 in 73 (4%) 3 in 73 (4%) 5 in 73 (7%) Present Present Mild No
2* No previous symptoms, found unresponsive 10 min after dinner in the bathroom, death within 10 h 4 mo 9 *Prednisone, fluticasone-salmeterol albuterol, montelukast None No 3 in 69 (4%) 0 in 69 (0%) 8 in 69 (11%) Present Present Moderate-severe Marked
3 5-d history of cold symptoms, could not awaken from sleep, cardiorespiratory arrest, death within 3 h 3 yr 8 Albuterol, fluticasone Esophageal reflux Mild 4 in 159 (2%) 9 in 159 (6%) 9 in 159 (6%) Present Present Mild-moderate Mild

Definition of abbreviations: BA = bronchial artery; IBA = intrapulmonary bronchopulmonary anastomosis; PA = pulmonary artery.

Clinical information and cardiac pathology data extracted from charts and autopsy reports are displayed. Quantification of airway-related microscopic pathology was done by reviewing all sampled lung tissues and counting all airways, including bronchi and bronchioli. Age-matched control was a 6-year-old girl with unexplained sudden death with a remote history of idiopathic cardiomyopathy.

*

Patient 2 did not take these prescribed medications prior 5 months, owing to insurance issues.